CLEVELAND, Ohio – The latest research on the coronavirus suggests low doses of aspirin could help improve outcomes for patients hospitalized with COVID-19, and that being infected a second time is rare but more likely among seniors.
Cleveland.com is rounding up some of the most notable coronavirus news making headlines online. Here’s what you need to know for Friday, March 19:
Low-dose aspirin could help hospitalized COVID-19 patients, study says
Treating hospitalized COVID-19 patients with low-dose aspirin resulted in a 44% reduction in the risk of needing a ventilator, a 43% reduction the risk of ICU admission and a 47% reduction for the risk of death, a new study found.
George Washington University researchers used data from 400 patients admitted to hospitals in the U.S. to reach their conclusions, which were published in the journal Anesthesia & Analgesia. The study only reviewed data from hospitalized patients, and experts have previously told cleveland.com that taking aspirin as a precaution in case you contract COVID-19 is a dangerous idea.
Chance of COVID-19 reinfection low, but immunity is lower among the elderly
Being infected with COVID-19 a second time is rare and occurs in less than 1% of individuals who contracted the virus, according to a study published in The Lancet. The study used data from Denmark to conclude that most people have a roughly 80% immunity from being infected again for at least six months. However, people aged 65 and older have a much lower immunity of less than 50% for six months, the study found.
Vitamin D did not effect length of stay for hospitalized COVID-19 patients
A study published in the Journal of the American Medical Association found a single dose of Vitamin D did not reduce the length of time a coronavirus patient remained in the hospital. Patients who were given Vitamin D were not aided, compared to patients who were given a placebo, the study says.
The findings indicate there is no benefit to giving Vitamin D to patients with moderate to severe COVID-19, the researchers wrote.
Pilot study says female hormone could help male COVID-19 patients
A small pilot study involving 40 men found progesterone, a hormone used in fertility-related conditions in women, could help improve outcomes for men hospitalized with COVID-19. Researchers from Cedars-Sanai found men had generally better clinical outcomes when they were treated with the hormone. More data is needed to draw a definitive conclusion on the hormone’s effectiveness, the study says.
European Union says AstraZeneca vaccine is safe and effective
The European Medicines Agency said Thursday that the Oxford-AstraZeneca vaccine is not associated with blood clots. The EUA conducted a review after 13 nations stopped using the vaccine over fears it caused blood clots. The World Health Organization has urged countries to keep using the vaccine, and plans to release its own review on Friday.
"low" - Google News
March 19, 2021 at 04:13PM
https://ift.tt/2P3vqc2
Low-dose aspirin could help hospitalized patients; seniors more likely to be reinfected, study suggests: Coro - cleveland.com
"low" - Google News
https://ift.tt/2z1WHDx
Bagikan Berita Ini
0 Response to "Low-dose aspirin could help hospitalized patients; seniors more likely to be reinfected, study suggests: Coro - cleveland.com"
Post a Comment